Gelest

Gelest

Gelest was founded in 1991 by Barry Arkles, a materials scientist and entrepreneur. The company produces specialty silane, silicone, metal-organic, and acrylate compounds sold into advanced technology markets. In 2019 Gelest acquired Bimax, gaining additional acrylate chemistry capabilities. The firm became part of Mitsubishi Chemical Group in 2020. The company's products serve five core application categories: microelectronics (ALD and CVD precursors, dielectric materials), medical devices (contact lenses, optical materials), personal care (cosmetic fluids, surface treatment), CASE (coatings, adhesives, sealants, elastomers), and life science tools (separation science, antimicrobials). Gelest operates R&D and manufacturing facilities in Morrisville and Glen Rock, Pennsylvania, with a global footprint spanning North America, Europe, and Asia through direct sales branches, distributors, and logistics centers. Gelest does not disclose financial metrics such as revenue or AUM, as its nature is an operating company, not an investment vehicle. The firm employs a technical workforce focused on custom compound development. A notable recent event came in February 2026, when Gelest announced a collaboration with IBM to test dry resist EUV lithography precursors (per firm press release, February 2026). Its structural differentiator lies in being an operating company within the Mitsubishi Chemical Group rather than a passive holding. The firm actively manufactures and sells high-purity chemical intermediates used in semiconductor manufacturing, pharmaceutical development, and biomedical applications. This positions Gelest as a direct participant in advanced manufacturing supply chains rather than an investment allocator.